Results 81 to 90 of about 27,626 (220)

In Vitro Amphotericin B Resistance in Clinical Isolates of Aspergillus terreus , with a Head-to-Head Comparison to Voriconazole [PDF]

, 1999
Deanna A. Sutton, Stephen Sanche, Sanjay G. Revankar, Annette W. Fothergill, Michael G. Rinaldi   +4 more
openalex   +1 more source

INTERNATIONAL MULTICENTER EXPERIENCE IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN IMMUNOCOMPROMISED CANCER PATIENTS

Mediterranean Journal of Hematology and Infectious Diseases, 2019
BACKGROUND: Invasive aspergillosis (IA) is a life-threatening infection in immunocompromised patients. In this study, we compared the efficacy of voriconazole containing regimen vs non-voriconazole containing regimen in patients with IA.
R. Hachem, Marjorie Batista, Souha S Kanj, Saaed El Zein, Sara Haddad, Ying Jiang, Nobuyoshi Mori, Rocha Vanderson, Anne-Marie Chaftari, Issam I Raad   +9 more
doaj   +1 more source

In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates. [PDF]

, 1998
Paul E. Verweij, Marco Mensink, Anthonius Rijs, J. Peter Donnelly, Jacques F. Meis, David W. Denning   +5 more
openalex   +1 more source

Neurologic Adverse Events Associated with Voriconazole Therapy: Report of Two Pediatric Cases

Case Reports in Infectious Diseases, 2016
Although voriconazole, a triazole antifungal, is a safe drug, treatment with this agent is associated with certain adverse events such as hepatic, neurologic, and visual disturbances.
Sevliya Öcal Demir, Serkan Atici, Gülşen Akkoç, Nurhayat Yakut, Nilay Baş İkizoğlu, Ela Erdem Eralp, Ahmet Soysal, Mustafa Bakir   +7 more
doaj   +1 more source

In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients [PDF]

, 1999
Mónica Chávez, Samuel Bernal, Anastasio Valverde, M. J. Gutiérrez, Guillermo Quindós, Estrella Martín‐Mazuelos   +5 more
openalex   +1 more source

Influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

BMC Pediatrics
Purpose We aimed to investigated the influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Methods This was a prospective cohort design study.
Ting Zhao, Hui-lan Zhang, Hao Shen, Jie Feng, Ting-ting Wang, Hong-jian Li, Lu-hai Yu   +6 more
doaj   +1 more source

Damage to yeast cells ofCryptococcus neoformansby voriconazole and fluconazole: a culture and microscopic study [PDF]

, 1998
Elmer Brummer, Katsuhiko Kamei, Makoto Miyaji   +2 more
openalex   +1 more source

Meningitis Caused by Pseudallescheria boydii Treated with Voriconazole [PDF]

, 2000
G. Poza, José G. Montoya, Carmen Brufau Redondo, Juan Pablo Medellín, N. Vila, J. L. Rodríguez-Tudela, Areli Bautista Cerón, E. Simarro   +7 more
openalex   +1 more source

Voriconazole-induced periostitis [PDF]

European Journal of Nuclear Medicine and Molecular Imaging, 2011
Christine, Rossier, Vincent, Dunet, Frederic, Tissot, Berengère, Aubry-Rozier, Oscar, Marchetti, Olivier, Marchetti, Ariane, Boubaker   +6 more
openaire   +5 more sources

Efficacy of Voriconazole in a Guinea Pig Model of Disseminated Invasive Aspergillosis [PDF]

, 2000
William R. Kirkpatrick, Robert K. McAtee, Annette W. Fothergill, Michael G. Rinaldi, Thomas F. Patterson   +4 more
openalex   +1 more source